being with Peregrine for such a short time (under 6 months, because once linkedin sees that you work 6 months and 1 day they call that 7 months and so on..) but anyhow, I wonder the cutoff would be to even get into this conference as a speaker ?
What I'm getting at is I think Peregrine wanted a presence at this conference and required the talent of sufficient needs to do so and like CP's cat going wall A to wall B does Lisa Stepp truly working alongside both companies as her profile states ...?
My oh my... or Peregrine employees playing games and laughing as we wait... : )
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!